Projects per year
Personal profile
Research interests
Pulmonary vascualr disease and right ventricular dysfunction. Currently studying the safety and efficacy of beta-blockers in the treatment of right ventricualr dysfunction due to pulmonary arterial hypertension.
Personal profile
Thenappan Thenappan is an Assisatnt Professor in the Department of Medicine at the University of Minnesota. Minneapolis, MN. He is a memeber of American Heart Association, American Thoracic Society, International Society of Heart and Lung Transplant, Pulmonary Vascualr Research Institute, and Pulmonary Hypertension Association. He has published on pulmonary vascualr disease and right ventricuar dysfunction in high impact factor journals including Circulation, Circulation Heart Failure, Journal of American College of Cardiology, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, and Chest.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research interests
- Pulmonary vascualr disease
- Right ventricular dysfunction
- Right heart failure
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension
Chang, K. Y., Giorgio, K., Schmitz, K., Walker, R. F., Prins, K. W., Pritzker, M. R., Archer, S. L., Lutsey, P. L. & Thenappan, T., Mar 21 2023, In: Journal of the American Heart Association. 12, 6, e027559.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Ketone bodies in right ventricular failure: A unique therapeutic opportunity
Blake, M., Puchalska, P., Kazmirczak, F., Blake, J., Moon, R., Thenappan, T., Crawford, P. A. & Prins, K. W., Nov 2023, In: Heliyon. 9, 11, e22227.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
Waxman, A., Restrepo-Jaramillo, R., Thenappan, T., Engel, P., Bajwa, A., Ravichandran, A., Feldman, J., Hajari Case, A., Argula, R. G., Tapson, V., Smith, P., Deng, C., Shen, E. & Nathan, S. D., Jun 1 2023, In: The European respiratory journal. 61, 6Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Outcomes of Patients Referred for Cardiac Rehabilitation after Left Ventricular Assist Device Implantation
Shaaban, A., Schultz, J., Leonard, J., Martin, C. M., Kamdar, F., Alexy, T., Thenappan, T., Pritzker, M., Shaffer, A., John, R. & Cogswell, R., Mar 1 2023, In: ASAIO Journal. 69, 3, p. 304-308 5 p.Research output: Contribution to journal › Article › peer-review
-
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites
Moutsoglou, D. M., Tatah, J., Prisco, S. Z., Prins, K. W., Staley, C., Lopez, S., Blake, M., Teigen, L., Kazmirczak, F., Weir, E. K., Kabage, A. J., Guan, W., Khoruts, A. & Thenappan, T., Mar 15 2023, In: American journal of respiratory and critical care medicine. 207, 6, p. 740-756 17 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations